Answers are grounded in this paper and cite their sources.
Rheumatoid arthritis (RA) is a chronic autoimmune disease with substantial global health implications. Although conventional synthetic disease modifying antirheumatic drugs (DMARDs) afford symptomatic control, their considerable adverse effects underscore the urgent need for safer and more efficacious therapeutic alternatives. Natural product monomers have demonstrated marked anti-arthritic potential. This review systematically delineates the pharmacological activities and molecular mechanisms of natural product monomers, such as alkaloids, terpenoids, flavonoids, glycosides, and quinones in modulating immune homeostasis, attenuating inflammation, and inhibiting synovial hyperplasia. It further identifies significant translational limitations, such as the poor bioavailability and aqueous solubility, uncertain safety and scant clinical data, pose substantial challenges to new drug development based on natural product monomers.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: